AUTOIMMUNE BRAIN PANEL
LIVE

Serial Number

98526858

Owner

Moleculera Biosciences, Inc.

Attorney

David M. Sullivan

First Use Date

Mar 5, 2024

Filing Date

Apr 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AUTOIMMUNE BRAIN PANEL Trademark

Serial Number: 98526858 • Registration: 7734072

AUTOIMMUNE BRAIN PANEL is a trademark filed by Moleculera Biosciences, Inc. on April 30, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Moleculera Biosciences, Inc. (2 trademarks)

755 Research Parkway, Suite 410
Oklahoma City, OK 73104

Entity Type: 03

Trademark Details

Filing Date

April 30, 2024

Registration Date

March 18, 2025

First Use Anywhere

March 5, 2024

First Use in Commerce

March 5, 2024

Goods & Services

Antibody testing for medical diagnostic or treatment purposes; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Blood serum testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes; Immunochemical medical diagnostic testing services for detecting and measuring antibody levels

Clinical research in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Laboratory testing of materials; Medical and scientific research information in the field of autoimmune neuropsychiatric disorders, and other immune mediated disorders, such as cardiovascular, long-covid, and cognitive disorders, symptoms, testing, and treatment; Providing a website featuring educational information in the field of clinical research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Mar 18, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Feb 21, 2025 CNTA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2024 DOCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 16, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2024 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2024 NWOS
NEW APPLICATION ENTERED
Apr 30, 2024 NWAP